111 related articles for article (PubMed ID: 36876366)
21. TB/HIV co-infections and associated factors among patients on directly observed treatment short course in Northeastern Ethiopia: a 4 years retrospective study.
Mekonnen D; Derbie A; Desalegn E
BMC Res Notes; 2015 Nov; 8():666. PubMed ID: 26559922
[TBL] [Abstract][Full Text] [Related]
22. An observational cohort study of bacterial co-infection and implications for empirical antibiotic therapy in patients presenting with COVID-19 to hospitals in North West London.
Wang L; Amin AK; Khanna P; Aali A; McGregor A; Bassett P; Gopal Rao G
J Antimicrob Chemother; 2021 Feb; 76(3):796-803. PubMed ID: 33185241
[TBL] [Abstract][Full Text] [Related]
23. Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia.
van Dalen EC; Mank A; Leclercq E; Mulder RL; Davies M; Kersten MJ; van de Wetering MD
Cochrane Database Syst Rev; 2012 Sep; (9):CD006247. PubMed ID: 22972091
[TBL] [Abstract][Full Text] [Related]
24. The significance of pulmonary nodule in breast cancer patients.
Daglar G; Yuksek YN; Gozalan U; Tutuncu T; Kama NA
Bratisl Lek Listy; 2010; 111(5):280-3. PubMed ID: 20568418
[TBL] [Abstract][Full Text] [Related]
25. Clinical experience with an L-proline–stabilized 10 %intravenous immunoglobulin (Privigen®): real-life effectiveness and tolerability.
Dorsey MJ; Ho V; Mabudian M; Soler-Palacín P; Domínguez-Pinilla N; Rishi R; Rishi R; Wong D; Rojavin M; Hubsch A; Berger M
J Clin Immunol; 2014 Oct; 34(7):804-12. PubMed ID: 24981039
[TBL] [Abstract][Full Text] [Related]
26. Enterococcal periprosthetic joint infection: clinical and microbiological findings from an 8-year retrospective cohort study.
Renz N; Trebse R; Akgün D; Perka C; Trampuz A
BMC Infect Dis; 2019 Dec; 19(1):1083. PubMed ID: 31881851
[TBL] [Abstract][Full Text] [Related]
27. Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer.
Zaheed M; Wilcken N; Willson ML; O'Connell DL; Goodwin A
Cochrane Database Syst Rev; 2019 Feb; 2(2):CD012873. PubMed ID: 30776132
[TBL] [Abstract][Full Text] [Related]
28. Trastuzumab in the adjuvant treatment of breast cancer.
Svetlovska D; Mardiak J; Kristova V
Bratisl Lek Listy; 2007; 108(2):100-3. PubMed ID: 17685010
[TBL] [Abstract][Full Text] [Related]
29. Bone mineral density in early breast cancer patients.
Spanik S; Spanikova B
Bratisl Lek Listy; 2010; 111(1):27-32. PubMed ID: 20429308
[TBL] [Abstract][Full Text] [Related]
30. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
[TBL] [Abstract][Full Text] [Related]
31. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Herath SC; Normansell R; Maisey S; Poole P
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009764. PubMed ID: 30376188
[TBL] [Abstract][Full Text] [Related]
32. The effect of warfarin administration on platelet aggregation.
Chylova M; Motovska Z; Fialova A; Stetkarova I; Peisker T; Kalvach P
Bratisl Lek Listy; 2021; 122(5):320-324. PubMed ID: 33848181
[TBL] [Abstract][Full Text] [Related]
33. Study on possibilities of reconstructive--plastic surgery in patients with stage III breast cancer.
Ismagilov AK; Khasanov RS; Navrusov SN; Beknazarov ZP
Bratisl Lek Listy; 2011; 112(12):686-90. PubMed ID: 22372333
[TBL] [Abstract][Full Text] [Related]
34. Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: a retrospective cohort study utilizing the Cubicin Outcomes Registry and Experience.
Sakoulas G; Brown J; Lamp KC; Friedrich LV; Lindfield KC
Clin Ther; 2009 Sep; 31(9):1936-45. PubMed ID: 19843483
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular events and atherogenic lipid profile in chronic myeloid leukemia patients treated with nilotinib versus imatinib.
Petrikova L; Slezakova K; Sninska Z; Harvanova L; Martisova M; Hatalova A; Mistrik M; Batorova A; Mladosievicova B
Bratisl Lek Listy; 2021; 122(8):531-537. PubMed ID: 34282617
[TBL] [Abstract][Full Text] [Related]
36. Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy.
Skoetz N; Bohlius J; Engert A; Monsef I; Blank O; Vehreschild JJ
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007107. PubMed ID: 26687844
[TBL] [Abstract][Full Text] [Related]
37. The administration of adjuvant chemo(-immuno) therapy in the post ACOSOG-Z0011 era; a population based study.
Poodt IGM; Rots ML; Vugts G; van Dalen T; Kuijer A; Vriens BEPJ; Nieuwenhuijzen GAP; Schipper RJ
Eur J Surg Oncol; 2018 Aug; 44(8):1151-1156. PubMed ID: 29580733
[TBL] [Abstract][Full Text] [Related]
38. Assessment of 25-Year Survival of Women With Estrogen Receptor-Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy: A Secondary Analysis of Data From the Stockholm Tamoxifen Randomized Clinical Trial.
Dar H; Johansson A; Nordenskjöld A; Iftimi A; Yau C; Perez-Tenorio G; Benz C; Nordenskjöld B; Stål O; Esserman LJ; Fornander T; Lindström LS
JAMA Netw Open; 2021 Jun; 4(6):e2114904. PubMed ID: 34190995
[TBL] [Abstract][Full Text] [Related]
39. Risk assessment of hepatotoxicity among tuberculosis and human immunodeficiency virus/AIDS-coinfected patients under tuberculosis treatment.
Ngouleun W; Biapa Nya PC; Pieme AC; Telefo PB
Int J Mycobacteriol; 2016 Dec; 5(4):482-488. PubMed ID: 27931691
[TBL] [Abstract][Full Text] [Related]
40. Root-end resection.
Blahuta R; Stanko P
Bratisl Lek Listy; 2012; 113(4):240-2. PubMed ID: 22502757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]